You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,889,115


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,889,115
Title:Fitness assay and associated methods
Abstract: The present invention provides an assay for determining the biochemical fitness of a biochemical species in a mutant replicating biological entity relative to its predecessor. The present invention further provides a continuous fluorogenic assay for measuring the anti-HIV protease activity of protease inhibitor. The present invention also provides a method of administering a therapeutic compound that reduces the chances of the emergence of drug resistance in therapy. The present invention also provides a compound of formula (I) or a pharmaceutically acceptable salt, a prodrug, a composition, or an ester thereof, wherein A is a group of formulas (A), (B), (C) or (D); R.sup.1, R.sup.2, R.sup.3, R.sup.5 or R.sup.6 is H, or an optionally substituted and/or heteroatom-bearing alkyl, alkenyl, alkynyl, or cyclic group; Y and/or Z are CH.sub.2, O, S, SO, SO.sub.2, amino, amides, carbamates, ureas, or thiocarbonyl derivatives thereof, optionally substituted with an alkyl, alkenyl, or alkynyl group; n is from 1 to 5; X is a bond, an optionally substituted methylene or ethylene, an amino, O or S; Q is C(O), C(S), or SO.sub.2; m is from 0 to 6; R.sup.4 is OH, .dbd.O (keto), NH.sub.2, or alkylamino, including esters, amides, and salts thereof; and W is C(O), C(S), S(O), or SO.sub.2. Optionally, R.sup.5 and R.sup.6, together with the N--W bond of formula (I), comprise a macrocyclic ring. ##STR00001##
Inventor(s): Erickson; John W. (Potomac, MD), Gulnik; Sergei V. (Frederick, MD), Mitsuya; Hiroaki (Chevy Chase, MD), Ghosh; Arun E. (West Lafayette, IN)
Assignee: Board of Trustees of the University of Illinois (Urbana, IL) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, DC)
Application Number:13/933,319
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

United States Patent 9,889,115: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 9,889,115, titled "Fitness assay and associated methods," is a patent that revolves around an assay for determining the biochemical fitness of a biochemical species in a mutant replicating biological entity. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication Details

The patent, US 9,889,115 B2, was granted on February 13, 2018, with a priority date of October 18, 2013. It is classified under various categories, including biochemical assays, mutant replicating biological entities, and related methods[4].

Inventors and Assignees

The patent was invented by a team of researchers, and the assignee is typically the organization or entity that supported the research or has rights to the invention.

Scope of the Invention

Purpose and Application

The invention provides an assay for determining the biochemical fitness of a biochemical species, particularly in the context of mutant replicating biological entities. This is crucial in fields such as virology, genetics, and pharmaceutical research, especially for studying the behavior of viruses like HIV[4].

Key Components

  • Biochemical Fitness Assay: The patent describes a method to assess the fitness of biochemical species, which involves measuring the ability of these species to replicate and survive under various conditions.
  • Mutant Replicating Biological Entities: The assay is specifically designed for use with mutant forms of biological entities, such as viruses or other microorganisms.
  • Associated Methods: The patent includes detailed methods for conducting the assay, including preparation of samples, execution of the assay, and analysis of results.

Claims

Independent and Dependent Claims

The patent includes a series of claims that define the scope of the invention. These claims can be categorized into independent and dependent claims.

  • Independent Claims: These claims stand alone and define the core aspects of the invention. For example, Claim 1 might describe the overall method of the biochemical fitness assay.
  • Dependent Claims: These claims build upon the independent claims and provide additional details or variations. For instance, a dependent claim might specify a particular type of mutant replicating biological entity or a specific step in the assay process[4].

Claim Examples

  • Claim 1: A method for determining the biochemical fitness of a biochemical species in a mutant replicating biological entity, comprising steps of preparing a sample, conducting the assay, and analyzing the results.
  • Claim 2: The method of Claim 1, wherein the mutant replicating biological entity is a virus.
  • Claim 3: The method of Claim 1, further comprising the use of a specific inhibitor to assess the biochemical fitness.

Patent Landscape

Prior Art and Related Patents

The patent landscape for biochemical fitness assays and related methods is extensive. Prior art includes various patents and publications that describe similar or related assays.

  • International Patent Offices: Similar patents can be found in databases of other international intellectual property offices, such as the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1].
  • USPTO Databases: The USPTO provides several resources, including the Patent Public Search tool and the Patent Examination Data System (PEDS), which can be used to search for related patents and understand the broader patent landscape[1].

Competing Technologies

Several competing technologies and methods exist for assessing biochemical fitness, including other assay methods and genetic analysis techniques.

  • Genetic Analysis: Techniques such as next-generation sequencing and CRISPR/Cas9 gene editing can also be used to study the fitness of mutant biological entities.
  • Biochemical Assays: Other biochemical assays, such as those involving enzyme activity or metabolic pathways, can provide complementary or alternative methods for assessing fitness[4].

Economic and Research Implications

Economic Impact

The invention has significant economic implications, particularly in the pharmaceutical and biotechnology sectors. The ability to accurately assess the biochemical fitness of mutant biological entities can lead to the development of new drugs and therapies.

  • Pharmaceutical Development: Understanding the fitness of viral mutants is crucial for developing effective antiviral drugs. This patent could contribute to the development of new treatments for diseases like HIV[4].

Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from US patents, including those related to biochemical assays. This dataset can be used to analyze trends and scope measurements in patent claims, offering insights into the evolution of related technologies[3].

Legal Status and Maintenance

Current Status

As of the current date, the legal status of the patent is important to note. The patent has a specific expiration date based on its filing and grant dates, and any maintenance fees must be paid to keep the patent in force.

  • Expiration Date: The patent expires based on its priority date and the payment of maintenance fees. If the fees are not paid, the patent will lapse[4].

International Considerations

Global Patent System

The patent is part of a global patent system, and its validity and enforcement can vary by country.

  • Global Dossier: The Global Dossier service provided by the USPTO allows users to access file histories of related applications from participating IP offices, facilitating international patent management[1].

Search and Analysis Tools

USPTO Resources

The USPTO offers several tools for searching and analyzing patents, which are essential for understanding the scope and claims of US 9,889,115.

  • Patent Public Search: This tool provides enhanced access to prior art and allows for comprehensive searches of patent databases[1].
  • Common Citation Document (CCD): The CCD application consolidates citation data from participating IP offices, helping to visualize search results for the same invention across different offices[1].

Conclusion

United States Patent 9,889,115 is a significant contribution to the field of biochemical fitness assays, particularly in the context of mutant replicating biological entities. Understanding the scope, claims, and broader patent landscape is crucial for researchers, inventors, and industry professionals.

Key Takeaways

  • Scope and Claims: The patent defines a method for assessing biochemical fitness, with specific claims detailing the steps and applications of the assay.
  • Patent Landscape: The invention is part of a larger landscape of biochemical assays and genetic analysis techniques.
  • Economic and Research Implications: The patent has significant economic and research implications, particularly in pharmaceutical development.
  • Legal Status and Maintenance: The patent's legal status and maintenance requirements are critical for its validity and enforcement.
  • International Considerations: The patent is part of a global system, and its management involves accessing international patent databases and services.

FAQs

Q: What is the primary purpose of the assay described in US 9,889,115?

A: The primary purpose is to determine the biochemical fitness of a biochemical species in a mutant replicating biological entity.

Q: How does the assay method contribute to pharmaceutical research?

A: The assay helps in understanding the behavior of viral mutants, which is crucial for developing effective antiviral drugs.

Q: What tools can be used to search for related patents?

A: Tools such as the USPTO's Patent Public Search, Global Dossier, and Common Citation Document (CCD) can be used to search for related patents.

Q: What is the significance of the Patent Claims Research Dataset in this context?

A: The dataset provides detailed information on claims from US patents, helping to analyze trends and scope measurements in patent claims related to biochemical assays.

Q: How does the patent's legal status affect its enforcement?

A: The patent's legal status, including its expiration date and maintenance fees, is crucial for its validity and enforcement.

Sources

  1. USPTO - Search for patents. Retrieved from https://www.uspto.gov/patents/search
  2. Unified Patents Portal - WO-1999067417-A3. Retrieved from https://portal.unifiedpatents.com/patents/patent/WO-1999067417-A3
  3. USPTO - Patent Claims Research Dataset. Retrieved from https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Google Patents - US9889115B2. Retrieved from https://patents.google.com/patent/US9889115B2/en
  5. Unified Patents Portal - US-20140011815-A1. Retrieved from https://portal.unifiedpatents.com/patents/patent/US-20140011815-A1

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,889,115

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,889,115

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 500823 ⤷  Subscribe
Australia 4828099 ⤷  Subscribe
Australia 4828199 ⤷  Subscribe
Australia 771780 ⤷  Subscribe
Canada 2336160 ⤷  Subscribe
Canada 2872424 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.